As I see it, the trial being an Open-Label study we should be able to get results, as the primary outcome measures are at 14 days and the secondary outcome measures are at 28 days, from the dosing of each of the patients. Moral grounds of the efficacy of apabetalone may dictate how this moves forward, as the results come in.

IMO ... Koo